Qnovia, Inc. reposted this
Qnovia, Inc., a Richmond, VA-based pharmaceutical company, raised $16M in Series B funding. Blue Ledge Capital, Evolution VC Partners, Vice Ventures, and Gaingels led the round. The company intends to use the funds to support the clinical, regulatory, and commercial development of its lead asset, RespiRx™ Nicotine Inhaler (QN-01), in the UK and to evaluate the feasibility of additional therapeutic indications in its pipeline. https://lnkd.in/gnuAkMAB